Site icon News As It Comes , India & World

COVAXIN Shows Impressive Safety And Immunogenicity Profile: Lancet

COVAXIN Shows Impressive Safety And Immunogenicity Profile

COVAXIN Shows Impressive Safety And Immunogenicity Profile

COVAXIN Shows Impressive Safety And Immunogenicity Profile: Lancet

COVAXIN Shows Impressive Safety And Immunogenicity Profile: Lancet

Bharat Biotech and Indian Council of Medical Research made COVID-19 vaccine ‘COVAXIN’ Phase 1 trial data has been released.

It has been showing safety, according to British medical journal Lancet.

Watch the video for more.

FacebookTwitterEmailPinterestWhatsAppTelegramLinkedInMessengerShare
Exit mobile version